Log in

Endoscopic Ultrasound-Guided Hepaticogastrostomy with Antegrade Stenting Without Dilation Device Application for Malignant Distal Biliary Obstruction in Pancreatic Cancer

  • Original Article
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Background

Endoscopic ultrasound-guided hepaticogastrostomy with antegrade stenting (EUS-HGAS) is a promising therapeutic option for malignant distal biliary obstruction (MDBO) in the event of transpapillary approach failure. Eliminating the fistula dilation step may further decrease the incidence of adverse events (AE) and simplify the procedure.

Aims

This study focused on MDBO associated with pancreatic cancer and aimed to examine the utility of EUS-HGAS without the use of any dilation devices.

Methods

This retrospective study investigated consecutive patients in whom the transpapillary approach had failed or was difficult, and who underwent EUS-HGAS without dilation device usage, using a tapered small-diameter catheter, ultrathin delivery system, and tapered dedicated plastic stent. The outcomes of this study included the technical success, clinical success, AE incidence, and recurrent biliary obstruction (RBO) associated with the procedure.

Results

During the study period, EUS-HGAS without dilation device usage was attempted for 57 patients with MDBO due to pancreatic cancer. The technical and clinical success rates were 91.2% (52/57) each. The median procedural time was 25 min. The rates of early and late AE besides RBO were 3.5% (2/57) and 1.9% (1/52), respectively. The incidence rate of RBO was 30.8% (16/52), and the median time to RBO was 245 days. The rate of successful endoscopic reintervention for RBO via the fistula was 100% (16/16).

Conclusions

EUS-HGAS without the use of dilation devices showed good technical feasibility with a low AE rate. It may be a useful option for MDBO associated with pancreatic cancer when the transpapillary approach is difficult.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Germany)

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. van der Merwe SW, van Wanrooij RLJ, Bronswijk M et al. Therapeutic endoscopic ultrasound: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 2022;54:185–205.

    Article  PubMed  Google Scholar 

  2. Teoh AYB, Dhir V, Kida M et al. Consensus guidelines on the optimal management in interventional EUS procedures: results from the Asian EUS group RAND/UCLA expert panel. Gut. 2018;67:1209–1228.

    Article  PubMed  Google Scholar 

  3. Isayama H, Nakai Y, Itoi T et al. Clinical practice guidelines for safe performance of endoscopic ultrasound/ultrasonography-guided biliary drainage: 2018. J Hepatobiliary Pancreat Sci. 2019;26:249–269.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Artifon EL, Marson FP, Gaidhane M, Kahaleh M, Otoch JP. Hepaticogastrostomy or choledochoduodenostomy for distal malignant biliary obstruction after failed ERCP: is there any difference? Gastrointest Endosc. 2015;81:950–959.

    Article  PubMed  Google Scholar 

  5. Nakai Y, Sato T, Hakuta R et al. Long-term outcomes of a long, partially covered metal stent for EUS-guided hepaticogastrostomy in patients with malignant biliary obstruction (with video). Gastrointest Endosc. 2020;92:623–631.

    Article  PubMed  Google Scholar 

  6. Giovannini M. EUS-guided hepaticogastrostomy. Endosc Ultrasound. 2019;8:S35–S39.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Paik WH, Park DH. Outcomes and limitations: EUS-guided hepaticogastrostomy. Endosc Ultrasound. 2019;8:S44–S49.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Ogura T, Masuda D, Imoto A et al. EUS-guided hepaticogastrostomy combined with fine-gauge antegrade stenting: a pilot study. Endoscopy. 2014;46:416–421.

    Article  PubMed  Google Scholar 

  9. Imai H, Takenaka M, Omoto S et al. Utility of endoscopic ultrasound-guided hepaticogastrostomy with antegrade stenting for malignant biliary obstruction after failed endoscopic retrograde cholangiopancreatography. Oncology. 2017;93:69–75.

    Article  PubMed  Google Scholar 

  10. Ogura T, Kitano M, Takenaka M et al. Multicenter prospective evaluation study of endoscopic ultrasound-guided hepaticogastrostomy combined with antegrade stenting (with video). Dig Endosc. 2018;30:252–259.

    Article  PubMed  Google Scholar 

  11. Yamamoto K, Itoi T, Tsuchiya T et al. EUS-guided antegrade metal stenting with hepaticoenterostomy using a dedicated plastic stent with a review of the literature (with video). Endosc Ultrasound. 2018;7:404–412.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Inoue T, Ibusuki M, Kitano R et al. Endoscopic ultrasound-guided antegrade radiofrequency ablation and metal stenting with hepaticoenterostomy for malignant biliary obstruction: a prospective preliminary study. Clin Transl Gastroenterol. 2020;11:e00250.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Ishiwatari H, Ishikawa K, Niiya F, et al. Endoscopic ultrasound-guided hepaticogastrostomy versus hepaticogastrostomy with antegrade stenting for malignant distal biliary obstruction [published online ahead of print, 2022 Jan 30]. J Hepatobiliary Pancreat Sci. 2022;https://doi.org/10.1002/jhbp.1118.

  14. Zhang Y, Wang X, Sun K, et al. Application of endoscopic ultrasound-guided hepaticogastrostomy combined with antegrade stenting in patients with malignant biliary obstruction after failed ERCP [published online ahead of print, 2022 Feb 17]. Surg Endosc. 2022; https://doi.org/10.1007/s00464-022-09117-w.

  15. Ishiwatari H, Satoh T, Sato J et al. Bile aspiration during EUS-guided hepaticogastrostomy is associated with lower risk of postprocedural adverse events: a retrospective single-center study. Surg Endosc. 2021;35:6836–6845.

    Article  PubMed  Google Scholar 

  16. Yamamoto Y, Ogura T, Nishioka N et al. Risk factors for adverse events associated with bile leak during EUS-guided hepaticogastrostomy. Endosc Ultrasound. 2020;9:110–115.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Yoshida M, Naitoh I, Hayashi K et al. Various innovative roles for 3-Fr microcatheters in pancreaticobiliary endoscopy. Dig Endosc. 2022;34:632–640.

    Article  PubMed  Google Scholar 

  18. Umeda J, Itoi T, Tsuchiya T et al. A newly designed plastic stent for EUS-guided hepaticogastrostomy: a prospective preliminary feasibility study (with videos). Gastrointest Endosc. 2015;82:390-396.e2.

    Article  PubMed  Google Scholar 

  19. Matsunami Y, Itoi T, Sofuni A et al. EUS-guided hepaticoenterostomy with using a dedicated plastic stent for the benign pancreaticobiliary diseases: a single-center study of a large case series. Endosc Ultrasound. 2021;10:294–304.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Isayama H, Hamada T, Yasuda I et al. Tokyo criteria 2014 for transpapillary biliary stenting. Dig Endosc. 2015;27:259–264.

    Article  PubMed  Google Scholar 

  21. Cotton PB, Eisen GM, Aabakken L et al. A lexicon for endoscopic adverse events: report of an ASGE workshop. Gastrointest Endosc. 2010;71:446–454.

    Article  PubMed  Google Scholar 

  22. Kanda Y. Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant. 2013;48:452–458.

    Article  CAS  PubMed  Google Scholar 

  23. Park DH, Jang JW, Lee SS, Seo DW, Lee SK, Kim MH. EUS-guided biliary drainage with transluminal stenting after failed ERCP: predictors of adverse events and long-term results. Gastrointest Endosc. 2011;74:1276–1284.

    Article  PubMed  Google Scholar 

  24. Honjo M, Itoi T, Tsuchiya T et al. Safety and efficacy of ultra-tapered mechanical dilator for EUS-guided hepaticogastrostomy and pancreatic duct drainage compared with electrocautery dilator (with video). Endosc Ultrasound. 2018;7:376–382.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Ochiai K, Fujisawa T, Ishii S et al. Risk factors for stent migration into the abdominal cavity after endoscopic ultrasound-guided hepaticogastrostomy. J Clin Med. 2021;10:3111.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Hara K, Yamao K, Mizuno N et al. Endoscopic ultrasonography-guided biliary drainage: who, when, which, and how? World J Gastroenterol. 2016;22:1297–1303.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Kato S, Kuwatani M, Onodera M, et al. Risk of pancreatitis following biliary stenting with/without endoscopic sphincterotomy: a randomized controlled trial [published online ahead of print, 2021 Aug 13]. Clin Gastroenterol Hepatol. 2021;S1542-3565(21)00872-7. https://doi.org/10.1016/j.cgh.2021.08.016.

Download references

Acknowledgments

None

Funding

This study did not receive funding from any source.

Author information

Authors and Affiliations

Authors

Contributions

TI: conception and design, data acquisition, analysis and interpretation, and drafting and revision of the manuscript. RK: data acquisition and interpretation, and revision of the manuscript. MI, KS, SK, YK, YS, YN, KI, and MY: data interpretation and revision of the manuscript.

Corresponding author

Correspondence to Tadahisa Inoue.

Ethics declarations

Conflict of interest

Tadahisa Inoue received honoraria from KANEKA, outside of the submitted work. The other authors disclose no financial relationships relevant to this publication.

Ethical approval

The institutional review board of Aichi Medical University Hospital approved this study (Approval number: 2022-002), which was conducted in accordance with the principles of the Declaration of Helsinki.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 Video 1 Endoscopic ultrasound-guided hepaticogastrostomy with antegrade stenting without the use of dilation devices for malignant distal biliary obstruction in a patient with pancreatic cancer (MPG 54100 kb)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Inoue, T., Kitano, R., Ibusuki, M. et al. Endoscopic Ultrasound-Guided Hepaticogastrostomy with Antegrade Stenting Without Dilation Device Application for Malignant Distal Biliary Obstruction in Pancreatic Cancer. Dig Dis Sci 68, 2090–2098 (2023). https://doi.org/10.1007/s10620-022-07749-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-022-07749-5

Keywords

Navigation